THE RELATIONSHIP BETWEEN HAPTOGLOBIN POLYMORPHISM AND OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS

被引:4
作者
Hamad, Mawieh [1 ]
Awadallah, Samir [1 ]
Nasr, Hamzah [2 ]
机构
[1] Univ Sharjah, Dept Med Lab Sci, Sharjah, U Arab Emirates
[2] Specialty Med Labs, Amman, Jordan
关键词
chronic renal failure; ceruloplasmin ferroxidase activity; haptoglobin; hemodialysis; total antioxidant capacity; CERULOPLASMIN FERROXIDASE ACTIVITY; CHRONIC-RENAL-FAILURE; CARDIOVASCULAR-DISEASE; ANTIOXIDANT CAPACITY; DIALYSIS TREATMENT; KIDNEY-DISEASE; RISK-FACTOR; INFLAMMATION; PHENOTYPE; PROTEINS;
D O I
10.2478/jomb-2013-0019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The relationship between haptoglobin polymorphism and oxidative stress in hemodialysis patients is not fully understood. In this study, total antioxidant capacity and ceruloplasmin ferroxidase activity were evaluated in relation to haptoglobin phenotype distribution in hemodialysis patients. Methods: Serum samples collected from 161 patients and 84 healthy controls were haptoglobin-typed by electrophoresis. Ceruloplasmin ferroxidase activity and total antioxidant capacity were assayed using colorimetric methods. Results: Irrespective of the haptoglobin phenotype, patients exhibited significantly lower total antioxidant capacity (1.42+/-0.29 vs. 1.55+/-0.28 mmol/L, P=0.002) and higher ferroxidase activity than controls. Frequency of Hp1-1 and Hp2-1 in patients was 15.5% and 36% as compared with 9.5% and 41.7% in controls. While ferroxidase activity was lower in Hp2-2 patients than in controls (142+/-61 vs. 179+/-47 U/L, P=0.002), it was higher in Hp2-1 (173+/-56 U/L) and Hp1-1 (170+/-54 U/L) patients than in controls (141+/-43 and 99+/-30 U/L respectively) (P=0.002 and 0.009). Ferroxidase activity in Hp2-2 patients was significantly lower than that of Hp2-1 or Hp1-1 patients (P=0.004 and 0.034). Total antioxidant capacity was significantly lower only in Hp2-2 patients (1.44+/-0.25) compared to that in Hp2-2 controls (1.65+/-0.22) (P=0.000). Conclusions: These findings suggest that haptoglobin polymorphism can differentially impact oxidative stress levels in hemodialysis patients.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 40 条
[1]  
ANNUK M, 2003, KIDNEY INT S, V84, pS50
[2]   Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism [J].
Attieh, ZK ;
Mukhopadhyay, CK ;
Seshadri, V ;
Tripoulas, NA ;
Fox, PL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :1116-1123
[3]   A study of haptoglobin phenotypes in patients with chronic renal failure [J].
Awadallah, S ;
Hamad, M .
ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 :680-683
[4]   Role of haptoglobin phenotype in end-stage kidney disease [J].
Burbea, Z ;
Nakhoul, F ;
Rosenberg, S ;
Zoabi, R ;
Skorecki, K ;
Hochberg, I ;
Miller-Lotan, R ;
Benchetrit, S ;
Weissgarten, J ;
Knecht, A ;
Tovbin, D ;
Levy, NS ;
Levy, AP .
NEPHRON EXPERIMENTAL NEPHROLOGY, 2004, 97 (02) :E71-E76
[5]   Reduced serum ceruloplasmin levels in hereditary haemochromatosis [J].
Cairo, G ;
Conte, D ;
Bianchi, L ;
Fraquelli, M ;
Recalcati, S .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) :226-229
[6]   Haptoglobin Polymorphism as a Risk Factor for Chronic Kidney Disease: A Case-Control Study [J].
Chen, Yi-Chun ;
Lee, Ching-Chih ;
Huang, Chih-Yuan ;
Huang, Hsien-Bin ;
Yu, Chi-Chia ;
Ho, Yu-Chen ;
Su, Yu-Chieh .
AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (06) :510-514
[7]  
DAHLQVIST SR, 1988, HUM HERED, V38, P44
[8]  
Dakshinamurty K V, 2003, Clin Lab, V49, P255
[9]   Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis [J].
Filiopoulos, Vassilis ;
Hadjiyannakos, Dimitrios ;
Takouli, Lambrini ;
Metaxaki, Polixeni ;
Sideris, Vasilis ;
Vlassopoulos, Dimosthenis .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (12) :872-882
[10]   The physiopathological significance of ceruloplasmin - A possible therapeutic approach [J].
Floris, G ;
Medda, R ;
Padiglia, A ;
Musci, G .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (12) :1735-1741